NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 200 filers reported holding NEKTAR THERAPEUTICS in Q2 2017. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $25,000 | +31.6% | 1,092 | 0.0% | 0.01% | +20.0% |
Q1 2020 | $19,000 | -20.8% | 1,092 | 0.0% | 0.01% | 0.0% |
Q4 2019 | $24,000 | -48.9% | 1,092 | -57.9% | 0.01% | -54.5% |
Q3 2019 | $47,000 | -48.9% | 2,592 | 0.0% | 0.01% | -35.3% |
Q2 2019 | $92,000 | +5.7% | 2,592 | 0.0% | 0.02% | +13.3% |
Q1 2019 | $87,000 | +26.1% | 2,592 | +23.9% | 0.02% | +15.4% |
Q4 2018 | $69,000 | +3.0% | 2,092 | +91.6% | 0.01% | +18.2% |
Q3 2018 | $67,000 | +26.4% | 1,092 | 0.0% | 0.01% | +22.2% |
Q2 2018 | $53,000 | -90.9% | 1,092 | -80.0% | 0.01% | -92.0% |
Q1 2018 | $580,000 | +866.7% | 5,469 | +446.9% | 0.11% | +1030.0% |
Q4 2017 | $60,000 | +150.0% | 1,000 | 0.0% | 0.01% | +150.0% |
Q3 2017 | $24,000 | +20.0% | 1,000 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $20,000 | -13.0% | 1,000 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $23,000 | -30.3% | 1,000 | -66.7% | 0.00% | -69.2% |
Q1 2015 | $33,000 | -29.8% | 3,000 | 0.0% | 0.01% | -38.1% |
Q4 2014 | $47,000 | +30.6% | 3,000 | 0.0% | 0.02% | +16.7% |
Q3 2014 | $36,000 | -5.3% | 3,000 | 0.0% | 0.02% | 0.0% |
Q2 2014 | $38,000 | +22.6% | 3,000 | 0.0% | 0.02% | -10.0% |
Q3 2013 | $31,000 | -11.4% | 3,000 | 0.0% | 0.02% | -23.1% |
Q2 2013 | $35,000 | – | 3,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TIRSCHWELL & LOEWY INC | 588,908 | $7,138,000 | 1.23% |
Granahan Investment Management | 3,693,956 | $44,771,000 | 1.21% |
NEA Management Company, LLC | 1,825,600 | $22,126,000 | 1.09% |
FIC CAPITAL INC | 150,868 | $1,829,000 | 0.75% |
Rhenman & Partners Asset Management AB | 181,797 | $2,203,000 | 0.66% |
SOPHROSYNE CAPITAL LLC | 60,200 | $728,000 | 0.64% |
HARVEY CAPITAL MANAGEMENT INC | 130,400 | $1,580,000 | 0.63% |
Artal Group S.A. | 1,300,000 | $15,756,000 | 0.57% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 564,418 | $6,840,000 | 0.47% |
OppenheimerFunds, Inc. | 24,400,000 | $295,728,000 | 0.35% |